News Channels

16 Apr 2021 Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 Precision BioSciences Reacquires Global Rights to its Allogeneic CAR T Programs
16 Apr 2021 Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.
16 Apr 2021 Evobrutinib is the First and Only BTK Inhibitor to Demonstrate Reduction of a Key Biomarker of Neuronal Damage and Inflammation in Patients with MS
15 Apr 2021 INOVIO's COVID-19 Vaccine Candidate, INO-4800, Provides Broad Cross-reactive Immune Responses In Humans Against Variants of Concern
15 Apr 2021 Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiMTM Platform
15 Apr 2021 Merck to Discontinue Development of MK-7110 for COVID-19
15 Apr 2021 Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19
15 Apr 2021 Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)
15 Apr 2021 New protein degradation centre to lead drug discovery revolution
15 Apr 2021 Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) in Combination with Cabometyx (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
15 Apr 2021 GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist
14 Apr 2021 Agenus Doses First Cancer Patient with iNKT Cell Therapy
14 Apr 2021 Aquavit to Introduce A New Botulinum Toxin (DTX-021)
14 Apr 2021 TriSalus Life Sciences Presents Data at American Association of Cancer Research Showing Reduced Liver Tumor Burden from Toll-Like Receptor Agonists
14 Apr 2021 TILT Biotherapeutics and MSD to Collaborate on Clinical Trial of Adenoviral Cancer Immunotherapeutic TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer
14 Apr 2021 U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
13 Apr 2021 Peptilogics Announces Successful Completion of Phase 1 Clinical Trial of PLG0206, a First-in-Class Anti-Infective Peptide Therapy
13 Apr 2021 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
13 Apr 2021 Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up